Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients
JJ Noubiap, JR Nansseu, UF Nyaga, PS Sime… - Heart, 2019 - heart.bmj.com
Objective We conducted the first systematic review and meta-analysis to estimate the
specific prevalence of apparent treatment-resistant, pseudo-resistant and true-resistant …
specific prevalence of apparent treatment-resistant, pseudo-resistant and true-resistant …
Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension
E Berra, M Azizi, A Capron, A Høieggen, F Rabbia… - …, 2016 - Am Heart Assoc
298 Hypertension August 2016 drug adherence. Assessment of adherence is not part of
routine clinical practice and is seldom performed in studies, even those testing drugs or …
routine clinical practice and is seldom performed in studies, even those testing drugs or …
Association between BNT162b2 vaccination and incidence of SARS-CoV-2 infection in pregnant women
Importance Data on BNT162b2 messenger RNA (mRNA) vaccine (Pfizer-BioNTech)
effectiveness and safety in pregnancy are currently lacking because pregnant women were …
effectiveness and safety in pregnancy are currently lacking because pregnant women were …
Odds of testing positive for SARS-CoV-2 following receipt of 3 vs 2 doses of the BNT162b2 mRNA vaccine
Importance With the evidence of waning immunity of the mRNA vaccine BNT162b2 (Pfizer-
BioNTech), a nationwide third-dose (booster) vaccination campaign was initiated in Israel …
BioNTech), a nationwide third-dose (booster) vaccination campaign was initiated in Israel …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) naturally acquired immunity versus vaccine-induced immunity, reinfections versus breakthrough …
S Gazit, R Shlezinger, G Perez, R Lotan… - Clinical Infectious …, 2022 - academic.oup.com
Background Waning of protection against infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) conferred by 2 doses of the BNT162b2 vaccine begins shortly …
coronavirus 2 (SARS-CoV-2) conferred by 2 doses of the BNT162b2 vaccine begins shortly …
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case …
Objective To examine the relative effectiveness of a fourth dose of the Pfizer-BioNTech
mRNA (BNT162b2) vaccine compared with three vaccine doses over the span of 10 weeks …
mRNA (BNT162b2) vaccine compared with three vaccine doses over the span of 10 weeks …
Epidemiology of endometriosis: a large population‐based database study from a healthcare provider with 2 million members
Objective Endometriosis constitutes a significant burden on the quality of life of women, their
families and healthcare systems. The objective of this study is to describe the real‐world …
families and healthcare systems. The objective of this study is to describe the real‐world …
The incidence of SARS-CoV-2 reinfection in persons with naturally acquired immunity with and without subsequent receipt of a single dose of BNT162b2 vaccine: a …
S Gazit, R Shlezinger, G Perez, R Lotan… - Annals of Internal …, 2022 - acpjournals.org
Background: There is insufficient evidence regarding the magnitude and durability of
protection conferred by a combined effect of naturally acquired immunity after SARS-CoV-2 …
protection conferred by a combined effect of naturally acquired immunity after SARS-CoV-2 …
Assessment of effectiveness of 1 dose of BNT162b2 vaccine for SARS-CoV-2 infection 13 to 24 days after immunization
Importance The BNT162b2 vaccine showed high efficacy against COVID-19 in a phase III
randomized clinical trial. A vaccine effectiveness evaluation in a real-world setting is …
randomized clinical trial. A vaccine effectiveness evaluation in a real-world setting is …
The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence
Background BNT162b2 vaccines showed high efficacy against COVID-19 in a randomised
controlled phase-III trial. A vaccine effectiveness evaluation in real life settings is urgently …
controlled phase-III trial. A vaccine effectiveness evaluation in real life settings is urgently …